These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30836703)

  • 21. A new mechanism of inactivation of the INK4/ARF locus.
    Gonzalez S; Serrano M
    Cell Cycle; 2006 Jul; 5(13):1382-4. PubMed ID: 16855387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
    Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
    Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.
    Williams RT; Barnhill LM; Kuo HH; Lin WD; Batova A; Yu AL; Diccianni MB
    PLoS One; 2014; 9(2):e88219. PubMed ID: 24505435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame.
    Yang J; Luan J; Yu Y; Li C; DePinho RA; Chin L; Richmond A
    Cancer Res; 2001 Nov; 61(22):8150-7. PubMed ID: 11719444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ARF-p53 senescence pathway in mouse and human cells.
    Wadhwa R; Sugihara T; Taira K; Kaul SC
    Histol Histopathol; 2004 Jan; 19(1):311-6. PubMed ID: 14702199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma.
    Vieth M; Schneider-Stock R; Röhrich K; May A; Ell C; Markwarth A; Roessner A; Stolte M; Tannapfel A
    Virchows Arch; 2004 Aug; 445(2):135-41. PubMed ID: 15185075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis.
    Matsuoka M; Kurita M; Sudo H; Mizumoto K; Nishimoto I; Ogata E
    Biochem Biophys Res Commun; 2003 Feb; 301(4):1000-10. PubMed ID: 12589812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
    Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
    Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
    Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
    Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Devereux TR; Patel AC; Foley JF; Maronpot RR; Massey TE
    Carcinogenesis; 2003 Jan; 24(1):121-32. PubMed ID: 12538357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
    Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
    Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
    Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
    Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
    Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.
    Eischen CM; Rehg JE; Korsmeyer SJ; Cleveland JL
    Cancer Res; 2002 Apr; 62(7):2184-91. PubMed ID: 11929842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy by ARF: a short story.
    Sherr CJ
    Mol Cell; 2006 May; 22(4):436-7. PubMed ID: 16713573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells.
    Bai M; Yu NZ; Long F; Feng C; Wang XJ
    Cell Physiol Biochem; 2016; 40(6):1367-1376. PubMed ID: 27997910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Ink4a/Arf locus in beta cell mass expansion under physiological and pathological conditions.
    Salas E; Rabhi N; Froguel P; Annicotte JS
    J Diabetes Res; 2014; 2014():873679. PubMed ID: 24672805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma.
    Kohno T; Yamada Y; Tawara M; Takasaki Y; Kamihira S; Tomonaga M; Matsuyama T
    Leuk Res; 2007 Dec; 31(12):1625-32. PubMed ID: 18246599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.